Mass spectrometry identification solution may help hospitals manage antimicrobial resistance more effectively FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global distribution of a complete portfolio of products for mass spectrometry that provides high-speed and high-confidence identification of pathogens in clinical laboratories ─ a […]
Today Biognosys announces the re-launch of its blood proteomics portfolio based on targeted proteomics technology. The existing PlasmaDive™ and PlasmaDeepDive™ Assay Panels will now be offered in 3 sizes for 20, 48 or 96 samples and will come with a license for SpectroDive™ software. In addition, stable isotope labeled standard (SIS) reference peptides needed for […]
First CE-IVD Kit for MALDI Biotyper-based Functional Testing of High Risk Carbapenemase Antibiotic Resistance (MBT STAR), CE-IVD MBT Mycobacteria IVD Library & Software for identification of 164 mycobacteria species, Further Enhancements for MALDI Biotyper-based Microbial Subtyping for Clinical Research, and Novel CE-IVD Genetic Assays with 2-3 Hours of Time to Result for Invasive Aspergillosis and […]
Today Biognosys announces the release of a new version of SpectroDive™ – Biognosys’ software for targeted proteomics. SpectroDive™ 8.0 now supports library generation from DDA results and subsequent panel generation for data acquisition with Multiple or Parallel Reaction Monitoring (MRM and PRM) workflows. Targeted proteomics is a powerful mass spectrometry based technique for highly specific and sensitive multiplexed quantification of selected proteins […]
Microsaic Systems plc (“Microsaic”, “Microsaic Systems” or the “Company”) Microsaic signs amended agreement with Global Partner Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announces that it has signed an amendment to its Research Collaboration Agreement with a long standing global partner. The amended agreement is a precursor to future collaboration […]
Biotransform solutions use the first commercial software to automate protein catabolite identification and speeds identification of metabolites and catabolites. FRAMINGHAM, Mass.–SCIEX, a global leader in life science analytical technologies, announced today the latest additions to its growing line of solutions for pharmaceutical drug discovery and development. The Routine Biotransform Solution and the Advanced Biotransform Solution […]
SCIEX industrialised proteomics solutions, using microflow SWATH® Acquisition, will accelerate cancer research Framingham, MA U.S.A. and Sydney, Australia — SCIEX, a global leader in life science analytical technologies, has announced that Children’s Medical Research Institute (CMRI) has opened ProCan™, the Australian Cancer Research Foundation International Centre for the Proteome of Human Cancer. The Centre has been set […]
SGS, a leading bio/pharmaceutical, analytical and bioanalytical contract solutions provider, today announced that it has invested in multiple highly sensitive and selective LC-MS/MS instruments at its Poitiers, France laboratory, for the quantification of proteins and peptide therapeutics. The two systems, which are now installed and validated, are a combination of the AB SCIEX 6500+ and […]
Greater Sensitivity and Accuracy for Life Science Research and Testing SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today expanded its portfolio of scientific instruments with a new LC/MS system that provides even greater sensitivity and accuracy for applications such as peptide quantitation, food safety, environmental testing, clinical research and forensic toxicology. The new Agilent […]
SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) introduces the latest addition to its portfolio of solutions for biopharmaceutical labs: the Agilent 6545XT AdvanceBio LC/Q-TOF MS System. Optimized to address analytical workflows commonly used in biopharma, the new LC/Q-TOF MS system combines high-performance liquid chromatography with robust quadrupole time-of-flight mass spectrometry and data-analysis tools. A […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
